R&D (Research & Development) plays a very important role in the success of a business. It is the R&D function that provides a platform for creativity and innovation to flourish in an organisation. Innovative breakthroughs have happened only because of painstaking efforts of the R&D function. Good quality research and development (R&D) is crucial to the long-term success of the Pharmaceutical and Nutraceutical industry and more generally, the wider life-sciences sector, but adequate funding is often required, particularly at the feasibility or concept stage of R&D.
Our team puts in a great deal of time and resources to promote our R&D department, this is in our quest to keep coming up with new kinds of products and dosage forms. Research and development (R&D) include activities that our company undertakes to innovate and introduce new products and services. It is often the first stage in the development process. The goal is typically to take new products and services to market and add to our company’s bottom line. Xania isn’t just a commercial venture, with our R&D department that is always working out the possibilities of bringing more and more innovation.
Our R&D team is headed by none other but by eminent Researcher and scholar who is one of our co-founders, he has has successfully developed pharmaceuticals dosage forms like Tablets, capsules, Dry Syrups, Liquid Orals, External preparations, Powders, Injectable, Lyophilized Injectables, Dry Powder Injectables, Veterinary Products, Herbal products, Cosmetics, Aerosols, Metered Dose Inhalers (MDI), Pellets, New Generation Antiseptic & Disinfectants and Nasal Sprays.
He has filed 6 Patents out of which 3 has been approved.
Research at Xania
Xania Research has been on the forefront of our business model from, even before the inception of Xania. With a firm belief in the principle that investing in research & development (R&D) is like serving mankind, Our early investments in R&D enabled us to make technology our key differentiator and develop a basket of robust products for diverse markets across the world. Our core strength lies in our ability to excel in developing generics and technologically complex products through focused teams in formulations, process chemistry and analytical development. We have the capability to deliver quality products within established timelines, at economical costs and without compromising on quality.
Our scientists work with cutting-edge enabling technologies for research. Our scientists have expertise in developing generics, difficult to make technology intensive products, Novel Drug Delivery Systems (NDDS).
Our capabilities span the development of differentiated products, such as Liposomal products, Inhalers, Lyophilized injections, Nasal sprays, Nutraceuticals innovative dosage forms such as Gummies, Lozenges, Effervescent Tablets, Next Generation Antiseptics & Disinfectant products and Herbal products besides developing controlled release dosage forms.
Our knowledge in Nutraceutical and Pharmaceutical research allows a rapid ramp-up of a diverse range of immediate and Novel Delivery Systems spanning Oral, Parenteral, Topical and Inhalation Dosage Forms. Our formulation expertise lies in the areas of taste masking, spray-drying, drug-layering, Lyophilization and other pharmaceutical unit operations that enable us to cater to various formulation design, needs and concepts. The ability to develop difficult-to-make, by using the latest technologies is the key differentiating factor of our research.
Xania Research & Development works closely with our business development team to generate innovative concepts and ideas, exploiting both market needs and synergies across therapeutic areas.
Over the years, we have developed expertise and gathered experience in performing pharmacokinetic and bioequivalence studies to facilitate the introduction of generic or branded generic drugs into the international market.
Our research strategy and implementation are well supported by a strong intellectual property team having expertise and experience in chemistry, analytical techniques, dosage forms and global patent law.